Skip to NavigationSkip to content

News

The US drug firm had been seeking recommendation in patients who have not responded to at least two different antidepressant therapies when...
Specifically, the approval concerns the first-line maintenance of locally advanced or metastatic urothelial carcinoma in patients whose disease has...
The National Academies of Sciences, Engineering and Medicine released a draft report saying it expects that “four of the trials will fail”, while...
The letter argues that the pill has “taken” more than 3.7 million pre-born lives, echoing popular right-wing pro-life narratives.
One teen has died after taking a large amounts of the antihistamine Benadryl as part of a social media “challenge” on popular video site TikTok.
The primary drive of the deal for Gilead is to secure exclusive licensing rights to Jounce’s JTX-1811, a monoclonal antibody which targets the...
The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.
The drug is orally administered semaglutide and is the world’s first glucagon-like peptide-1 receptor agonist pill (GLP-1 RA) for treating this form...
Aimmune’s work focuses on the treatment of food allergies, and the company made headlines in the end of January this year with the FDA approval of...
The COVID-19 news round-up this week focuses on coronavirus treatments, with Celltrion Group announcing that the Korean Ministry of Food and Drug...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches